Page last updated: 2024-08-23

bezafibrate and uric acid

bezafibrate has been researched along with uric acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bastow, MD; Durrington, PN; Ishola, M1
Inokuchi, T; Ka, T; Kobayashi, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T1
Behar, S; Boyko, V; Brodov, Y; Chouraqui, P; Goldenberg, I1
Behar, S; Boyko, V; Brodov, Y; Chouraqui, P1
Dohmen, K; Haruno, M; Tanaka, H1

Trials

3 trial(s) available for bezafibrate and uric acid

ArticleYear
Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial.
    Metabolism: clinical and experimental, 1988, Volume: 37, Issue:3

    Topics: Bezafibrate; Clinical Trials as Topic; Dietary Carbohydrates; Double-Blind Method; Fenofibrate; Fructose; Humans; Lipoproteins; Male; Propionates; Triglycerides; Uric Acid

1988
Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2007, Volume: 39, Issue:7

    Topics: Bezafibrate; Biomarkers; Body Mass Index; Fenofibrate; Gout; Humans; Hydrogen-Ion Concentration; Hypolipidemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Nephrolithiasis; PPAR alpha; Regression Analysis; Triglycerides; Uric Acid

2007
Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
    The American journal of cardiology, 2010, Dec-15, Volume: 106, Issue:12

    Topics: Aged; Bezafibrate; Blood Glucose; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hyperuricemia; Hypolipidemic Agents; Incidence; Israel; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Triglycerides; Uric Acid

2010

Other Studies

2 other study(ies) available for bezafibrate and uric acid

ArticleYear
Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    The American journal of cardiology, 2009, Jul-15, Volume: 104, Issue:2

    Topics: Aged; Analysis of Variance; Bezafibrate; Biomarkers; C-Reactive Protein; Cohort Studies; Confidence Intervals; Coronary Artery Disease; Endpoint Determination; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Uric Acid

2009
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.
    Fukuoka igaku zasshi = Hukuoka acta medica, 2013, Volume: 104, Issue:10

    Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; PPAR alpha; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Uric Acid; Ursodeoxycholic Acid

2013